Hereditary Cancer & Genetics: Twenty Year Anniversary of BRCA1

Pictured: Mark Robson, Noah Kauff, Zsofia Stadler & Kenneth Offit (Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.

The recent film “Decoding Annie Parker” chronicles the discovery of BRCA1, an inherited gene mutation associated with an increased risk of breast and ovarian cancers. Together with uncovering BRCA2, the breakthrough transformed the way doctors aim to prevent and treat hereditary cancers.

Since BRCA1’s discovery, in 1994, Memorial Sloan Kettering specialists have continued to make significant strides in hereditary genetics. Learn more about the last 20 years’ progress and our current hereditary genetics research.

20 Years of Progress in Understanding Hereditary Breast Cancer Enlarge Image 20 Years of Progress in Understanding Hereditary Breast Cancer

More on BRCA1 & BRCA2

More on Hereditary Cancer Genetics